The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells

Targeting the bone microenvironment in multiple myeloma

(2010) G. David Roodman   JOURNAL OF BONE AND MINERAL METABOLISM

The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor

(2009) Anne Catherine Sprynski et al.   BLOOD

GM-CSF and IL-4 induce dendritic cell differentiation and disrupt osteoclastogenesis through M-CSF receptor shedding by up-regulation of TNF-  converting enzyme (TACE)

(2009) M. Hiasa et al.   BLOOD

Antimyeloma Activity of the Orally Bioavailable Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235

(2009) D. W. McMillin et al.   CANCER RESEARCH

Multiple myeloma

(2009) Marc S Raab et al.   LANCET

Novel benzylidene-thiazolidine-2,4-diones inhibit Pim protein kinase activity and induce cell cycle arrest in leukemia and prostate cancer cells

(2009) Z. Beharry et al.   MOLECULAR CANCER THERAPEUTICS

The role of the insulin-like growth factor 1 receptor axis in multiple myeloma

(2009) Eline Menu et al.   ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY

Synthesis and Evaluation of Novel Inhibitors of Pim-1 and Pim-2 Protein Kinases

(2008) Zuping Xia et al.   JOURNAL OF MEDICINAL CHEMISTRY

Bone marrow microenvironment and the identification of new targets for myeloma therapy

(2008) K Podar et al.   LEUKEMIA